journal article Open Access Jun 02, 2020

PRKAA1 rs13361707 C/T polymorphism confers decreased susceptibility to esophageal cancer: A case‐control study

View at Publisher Save 10.1002/jcla.23406
Abstract
AbstractBackgroundSeveral studies probed into the connection between esophageal cancer (EC) risk and PRKAA1 rs13361707 C/T

polymorphism, but obtained insignificant findings.MethodsIn this study, 814 EC cases and 961

controls from Eastern China were recruited to validate the relationship between this polymorphism and EC susceptibility.ResultsData suggested rs13361707 C/T

polymorphism in PRKAA1 gene was significantly related with a lower risk for EC. Such significant connection was also uncovered in subgroups of males, smokers, drinkers and individuals with age ≥ 60 years. In addition, this polymorphism

was linked with the pathological grading, distant metastasis, and histology of EC.ConclusionIn summary, PRKAA1 rs13361707 C/T

polymorphism is related to the risk and clinical properties of EC patients in East China.
Topics

No keywords indexed for this article. Browse by subject →

Metrics
3
Citations
23
References
Details
Published
Jun 02, 2020
Vol/Issue
34(9)
License
View
Cite This Article
Cheng‐Lin Li, Jian‐Qiang Zhao, Bao Zang (2020). PRKAA1 rs13361707 C/T polymorphism confers decreased susceptibility to esophageal cancer: A case‐control study. Journal of Clinical Laboratory Analysis, 34(9). https://doi.org/10.1002/jcla.23406